|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q58001222
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010723.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q58001222
|
|
024
|
|
|
‡a
0000-0002-0145-4763
‡2
orcid
|
|
024
|
|
|
‡a
25825034500
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q58001222
|
|
100
|
0 |
|
‡a
Antoni Hurtado
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Antoni Hurtado
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A CTCF-independent role for cohesin in tissue-specific transcription
|
|
670
|
|
|
‡a
Author's A functional link between FOXA1 and breast cancer SNPs
|
|
670
|
|
|
‡a
Author's Cooperating transcription factors mediate the function of estrogen receptor
|
|
670
|
|
|
‡a
Author's CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions
|
|
670
|
|
|
‡a
Author's DNA methylation at enhancers identifies distinct breast cancer lineages
|
|
670
|
|
|
‡a
Author's Erratum: Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
|
|
670
|
|
|
‡a
Author's FOXA1 is a key determinant of estrogen receptor function and endocrine response
|
|
670
|
|
|
‡a
Author's Functional genomic methods to study estrogen receptor activity.
|
|
670
|
|
|
‡a
Author's High Throughput Chemical Screening Reveals Multiple Regulatory Proteins on FOXA1 in Breast Cancer Cell Lines
|
|
670
|
|
|
‡a
Author's Human SHBG mRNA translation is modulated by alternative 5'-non-coding exons 1A and 1B.
|
|
670
|
|
|
‡a
Author's Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate
|
|
670
|
|
|
‡a
Author's Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis
|
|
670
|
|
|
‡a
Author's Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles.
|
|
670
|
|
|
‡a
Author's Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen
|
|
670
|
|
|
‡a
Author's Switch in FOXA1 status associates with endometrial cancer progression
|
|
670
|
|
|
‡a
Author's The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
|
|
670
|
|
|
‡a
Author's Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells
|
|
909
|
|
|
‡a
(orcid) 0000000201454763
‡9
1
|
|
909
|
|
|
‡a
(scopus) 25825034500
‡9
1
|
|
919
|
|
|
‡a
highthroughputchemicalscreeningrevealsmultipleregulatoryproteinsonfoxa1inbreastcancercelllines
‡A
High Throughput Chemical Screening Reveals Multiple Regulatory Proteins on FOXA1 in Breast Cancer Cell Lines
‡9
1
|
|
919
|
|
|
‡a
identificationcharacterizationandexpressionofnovelsexhormonebindingglobulinalternative1exonsinthehumanprostate
‡A
Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate
‡9
1
|
|
919
|
|
|
‡a
identificationofmultipotentmesenchymalstromalcellsinthereactivestromaofaprostatecancerxenograftbysidepopulationanalysis
‡A
Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis
‡9
1
|
|
919
|
|
|
‡a
modulationofgenetranscriptionandepigeneticsofcoloncarcinomacellsbybacterialmembranevesicles
‡A
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles.
‡9
1
|
|
919
|
|
|
‡a
regulationoferbb2byoestrogenreceptorpax2determinesresponsetotamoxifen
‡A
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen
‡9
1
|
|
919
|
|
|
‡a
switchinfoxa1statusassociateswithendometrialcancerprogression
‡A
Switch in FOXA1 status associates with endometrial cancer progression
‡9
1
|
|
919
|
|
|
‡a
proapoptoticgeneinterferonregulatoryfactor1mediatestheantiproliferativeoutcomeofpairedbox2geneandtamoxifen
‡A
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
‡9
1
|
|
919
|
|
|
‡a
transducinlikeenhancerprotein1mediatesestrogenreceptorbindingandtranscriptionalactivityinbreastcancercells
‡A
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells
‡9
1
|
|
919
|
|
|
‡a
humanshbgmrnatranslationismodulatedbyalternative5noncodingexons1aand1b
‡A
Human SHBG mRNA translation is modulated by alternative 5'-non-coding exons 1A and 1B.
‡9
1
|
|
919
|
|
|
‡a
ctcfindependentroleforcohesinintissuespecifictranscription
‡A
A CTCF-independent role for cohesin in tissue-specific transcription
‡9
1
|
|
919
|
|
|
‡a
functionallinkbetweenfoxa1andbreastcancersnps
‡A
A functional link between FOXA1 and breast cancer SNPs
‡9
1
|
|
919
|
|
|
‡a
cooperatingtranscriptionfactorsmediatethefunctionofestrogenreceptor
‡A
Cooperating transcription factors mediate the function of estrogen receptor
‡9
1
|
|
919
|
|
|
‡a
ctcfmodulatesestrogenreceptorfunctionthroughspecificchromatinandnuclearmatrixinteractions
‡A
CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions
‡9
1
|
|
919
|
|
|
‡a
dnamethylationatenhancersidentifiesdistinctbreastcancerlineages
‡A
DNA methylation at enhancers identifies distinct breast cancer lineages
‡9
1
|
|
919
|
|
|
‡a
erratumregulationoferbb2byoestrogenreceptorpax2determinesresponsetotamoxifen
‡A
Erratum: Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
‡9
1
|
|
919
|
|
|
‡a
foxa1isakeydeterminantofestrogenreceptorfunctionandendocrineresponse
‡A
FOXA1 is a key determinant of estrogen receptor function and endocrine response
‡9
1
|
|
919
|
|
|
‡a
functionalgenomicmethodstostudyestrogenreceptoractivity
‡A
Functional genomic methods to study estrogen receptor activity.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000013682777
|
|
996
|
|
|
‡2
BNE|XX1351594
|
|
996
|
|
|
‡2
DNB|1056584033
|
|
996
|
|
|
‡2
BNE|XX981902
|
|
996
|
|
|
‡2
ISNI|000000005957144X
|
|
996
|
|
|
‡2
NYNYRILM|216516
|
|
996
|
|
|
‡2
BNCHL|10000000000000000114436
|
|
996
|
|
|
‡2
BNC|981061031471106706
|
|
996
|
|
|
‡2
SUDOC|153628537
|
|
996
|
|
|
‡2
BNF|16253430
|
|
996
|
|
|
‡2
PTBNP|1448979
|
|
996
|
|
|
‡2
DNB|132394804
|
|
996
|
|
|
‡2
BNE|XX1469485
|
|
996
|
|
|
‡2
BNE|XX1105098
|
|
996
|
|
|
‡2
DNB|141654856
|
|
996
|
|
|
‡2
DNB|1057108553
|
|
996
|
|
|
‡2
RERO|A023686679
|
|
996
|
|
|
‡2
BNE|XX825268
|
|
996
|
|
|
‡2
PTBNP|228456
|
|
996
|
|
|
‡2
BNE|XX4786898
|
|
996
|
|
|
‡2
ISNI|0000000117734738
|
|
996
|
|
|
‡2
BNE|XX1161554
|
|
996
|
|
|
‡2
PTBNP|1759174
|
|
996
|
|
|
‡2
BNE|XX1178763
|
|
996
|
|
|
‡2
NTA|067524249
|
|
996
|
|
|
‡2
DNB|118132067
|
|
996
|
|
|
‡2
SUDOC|132506939
|
|
996
|
|
|
‡2
ISNI|0000000062018215
|
|
996
|
|
|
‡2
BAV|495_200483
|
|
996
|
|
|
‡2
LC|no2009103963
|
|
996
|
|
|
‡2
BNC|981060547039006706
|
|
996
|
|
|
‡2
BNE|XX5049133
|
|
996
|
|
|
‡2
SUDOC|257952152
|
|
996
|
|
|
‡2
DNB|1157170013
|
|
996
|
|
|
‡2
BNCHL|10000000000000000064671
|
|
996
|
|
|
‡2
BNE|XX6324475
|
|
996
|
|
|
‡2
SUDOC|115594973
|
|
996
|
|
|
‡2
ISNI|0000000061080287
|
|
996
|
|
|
‡2
ISNI|0000000115027765
|
|
996
|
|
|
‡2
BNE|XX1159655
|
|
996
|
|
|
‡2
BIBSYS|5010915
|
|
996
|
|
|
‡2
DNB|1157292380
|
|
996
|
|
|
‡2
NII|DA12537973
|
|
996
|
|
|
‡2
DNB|143558706
|
|
996
|
|
|
‡2
ISNI|0000000377091206
|
|
996
|
|
|
‡2
ISNI|0000000110567826
|
|
996
|
|
|
‡2
BNE|XX974698
|
|
996
|
|
|
‡2
ISNI|000000014069173X
|
|
996
|
|
|
‡2
NUKAT|n 2016234070
|
|
996
|
|
|
‡2
BNC|981058511161506706
|
|
996
|
|
|
‡2
BNF|16190155
|
|
996
|
|
|
‡2
BNC|981058511261506706
|
|
996
|
|
|
‡2
NUKAT|n 2015142915
|
|
996
|
|
|
‡2
DNB|13148799X
|
|
996
|
|
|
‡2
BNF|14306529
|
|
996
|
|
|
‡2
LC|nr 95001087
|
|
996
|
|
|
‡2
NTA|121295389
|
|
996
|
|
|
‡2
SUDOC|071063811
|
|
996
|
|
|
‡2
LC|no2018022046
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
